Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of Sulbactam-Durlobactam holds promise for therapeutic intervention
A. Naha, S. Vijayakumar, B. Lal, B. A. Shankar, S. Chandran, S. Ramaiah, B. Veeraraghavan, A. Anbarasu
This study characterizes drug resistance in XDR Acinetobacter baumannii isolates and evaluates the efficacy of the novel Sulbactam-Durlobactam combination against carbapenemases.
bioRxiv · Aug 22, 2021Microbiology